Cbd Acid Biosynthesis

CBD acid biosynthesis refers to the enzymatic pathway through which cannabis plants produce cannabidiolic acid (CBDA), the acidic precursor to CBD. This metabolic process involves the activity of cannabidiolic acid synthase (CBDAS), an enzyme that catalyzes the conversion of geranylpyrophosphate and olivetolic acid into CBDA. The presence and efficiency of CBDAS activity largely determines whether a plant's chemical profile leans toward CBD-dominant or THC-dominant expression. Understanding CBD acid biosynthesis is foundational to cannabis genetics, as it underpins the distinction between chemotype I (THC-dominant), chemotype II (balanced), and chemotype III (CBD-dominant) plants. Breeders working with CBD-rich genetics study CBDAS gene expression and regulation to stabilize high-CBDA phenotypes across generations.

Breeders select for stable CBDAS enzyme expression to develop reliably CBD-dominant cultivars. Molecular markers targeting CBDAS genetic variation enable more precise prediction of offspring chemotypes during breeding programs.